Australia Cell And Gene Therapy Cdmo Market Size & Outlook

Name: Australia Cell And Gene Therapy Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The cell and gene therapy cdmo market in Australia is expected to reach a projected revenue of US$ 349.3 million by 2033. A compound annual growth rate of 23.5% is expected of Australia cell and gene therapy cdmo market from 2025 to 2033.

HC Outsourcing
- CMO/CDMO
  - Cell And Gene Therapy CDMO Market Outlook

Australia cell and gene therapy cdmo phase outlook (Revenue, USD million, 2021-2033)
- Pre-clinical
- Clinical
Australia cell and gene therapy cdmo indication outlook (Revenue, USD million, 2021-2033)
- Rare Diseases
- Others
- Oncology
- Infectious Diseases
- Neurological disorders
Australia cell and gene therapy cdmo product type outlook (Revenue, USD million, 2021-2033)
- Gene Therapy
  - Ex-vivo
  - In-vivo
- Gene-Modified Cell Therapy
  - CAR T-cell therapies
  - TCR-T cell therapy
  - Other
  - CAR-NK cell therapy
- Cell Therapy

Australia Cell And Gene Therapy Cdmo Market Size & Outlook

Data Tree

Sign up - it's easy, and free!